Medscape

Flawed PSA Data in SEER Make Past Studies Suspect

When the National Cancer Institute (NCI) removed all prostate-specific antigen (PSA) data from the Surveillance, Epidemiology, and End Results (SEER) and SEER-Medicare programs, it rendered many of ...
The American Journal of Managed Care

Urologist Evaluates Implications of the Removal of Flawed SEER PSA Data

Large data sets like SEER need better quality control checks and researchers and clinicians who use these data sets should also consider using secondary data analyses that answer specific research ...
Business Wire

Castle Biosciences Collaborates with the National Cancer Institute to Link DecisionDx®-Melanoma Testing Data with SEER Registries’ Cutaneous Melanoma Cases

Analysis of the first subset of linked SEER patient data demonstrates DecisionDx®-Melanoma testing was associated with improved overall survival rates compared to untested patients DecisionDx-Melanoma ...
ascopubs.org

Time Series Prediction of Lung Cancer Death Rates on the Basis of SEER Data

Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology Three models for yearly time series predictions were built: autoregressive integrated ...
Science Daily

Implications of flawed prostate specific antigen data in SEER

NCI recently announced that it had removed all PSA data from the SEER and SEER-Medicare programs. The data were removed after quality control checks revealed that a substantial number of PSA values ...